GUTS

Pomerantz LLP has filed a class action lawsuit against Fractyl Health, Inc. (NASDAQ: GUTS) and certain officers for alleged securities fraud. The lawsuit claims Defendants made materially false and misleading statements about the efficacy of Revita, their metabolic therapy device, while conducting public offerings in August-September 2025.

On January 29, 2026, Fractyl disclosed disappointing six-month data from the REMAIN-1 Midpoint Cohort showing only 4.5% weight regain versus 7.5% in the sham arm, significantly below expectations. The disclosure revealed operational issues at one clinical site compromised study integrity. Following the announcement, Fractyl's stock price plummeted 68.03% on January 29, 2026, and fell an additional 21.37% on January 30, 2026.

A class action lawsuit has been filed against Fractyl Health, Inc. for allegedly making materially false and misleading statements about its Revita product's effectiveness and clinical trial integrity during the Class Period of January 13, 2025 to January 29, 2026. Investors with losses are urged to contact the law firm before the October 20, 2026 lead plaintiff deadline. Similar lawsuits have also been filed against Taboola.com Ltd., AEVEX Corp., and Coastal Financial Corporation.

A class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that the company made materially false and misleading statements regarding its Revita product's effectiveness and clinical trial integrity. Investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026 have until October 20, 2026 to apply as lead plaintiff.

A class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that company executives made materially false and misleading statements regarding the effectiveness of its Revita product and the integrity of clinical trial results. The lawsuit covers investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026. The lead plaintiff deadline is October 20, 2026.

Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Flotek Industries, Aevex Corp, Fractyl Health, and GoDaddy Inc. The lawsuits allege materially false and misleading statements regarding business operations and prospects. Investors have until October 2026 to file lead plaintiff motions.

A class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that company executives made materially false and misleading statements about the effectiveness of its Revita product and the integrity of REMAIN-1 clinical trial results. Investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026 may be eligible to join the lawsuit, with a lead plaintiff deadline of October 20, 2026.

A class action lawsuit has been filed against Fractyl Health, Inc. for allegedly making materially false and misleading statements regarding its Revita product's effectiveness and clinical trial integrity during the period between January 13, 2025 and January 29, 2026. Investors who suffered losses are urged to contact the law firm by October 20, 2026 to participate in the action.